Background and Purpose: The ideal strategy to prevent infections in patients with external ventricular drains (EVDs) is unclear. Methods: We conducted a cross-sectional survey of members of the Neurocritical Care Society on infection prevention practices for patients with EVDs between April and July 2015. Results: The survey was completed by 52 individuals (5% response rate). Catheter selection, use of prolonged prophylactic systemic antibiotics (PPSAs), cerebrospinal fluid (CSF) collection policies, location of EVD placement, and performance of routine EVD exchanges varied. Antibiotic-impregnated catheters (AICs) and conventional catheters (CCs) were used with similar frequency, but no respondents reported routine use of silver-impregnated catheters (SICs). The majority of respondents were either neutral or disagreed with the need for PPSA with all catheter types (CC: 75%, AIC: 85%, and SIC: 87%). Despite this, 55% of the respondents reported PPSAs were routinely administered to patients with EVDs at their institutions. The majority (80%) of the respondents reported CSF collection only on an as-needed basis. The EVD placement was restricted to the operating room at 27% of the respondents' institutions. Only 2 respondents (4%) reported that routine EVD exchanges were performed at their institution. Conclusion: Practice patterns demonstrate that institutions use varying strategies to prevent ventriculostomy-related infections. Identification and further study of optimum care for these patients are essential to decrease the risk of complications and to aid development of practice standards.
Background
As the frequency of external ventricular drain (EVD) placement in neurosurgical patients has risen, practitioners have worked to minimize the risk of iatrogenic infections associated with these devices. 1 Reported rates of ventriculostomyrelated infections (VRIs) vary greatly (0%-45%). As with other health-care-associated infections, the target VRI rate is 0% 2,3 because the incidence of VRI is a marker of the quality of care in an intensive care unit (ICU). 4 There have been numerous publications addressing areas of improvement to prevent VRI, including catheter selection, [5] [6] [7] [8] [9] [10] [11] use of prolonged prophylactic systemic antibiotics (PPSA) throughout the duration of EVD placement, 7, 9, 10, [12] [13] [14] [15] [16] frequency of cerebrospinal fluid (CSF) sampling, [17] [18] [19] venue for EVD placement, 17, 20, 21 and the benefit of prophylactic EVD exchange. 5, 22, 23 We hypothesized that there is marked variation in EVD management strategies to prevent VRI. We sought to evaluate practice patterns in regard to these issues by surveying members of the Neurocritical Care Society about EVD management at their institutions.
Materials and Methods
An electronic survey on infection prevention for patients with EVDs was designed using Open RedCap (Research Electronic Data Capture, a secure, web-based application program hosted at NYU Langone Medical Center) 24 and distributed to approximately 1000 members of the Neurocritical Care Society via advertisement on the Society's website and in the Society's electronic newsletters from April to July 2015. Reminders were sent on a monthly basis throughout the study period.
Respondents were asked about demographic data, institutional EVD practices, and their personal beliefs on the need for PPSA with each catheter type (Appendix A, please note the survey also included questions about practices pertaining to other types of neurosurgical drains, but these results were reviewed separately).
Study data were analyzed using descriptive statistics and w 2 tests as appropriate. Intraclass correlation coefficient was calculated to assess the degree of variation in respondents' beliefs about the need for PPSA with each catheter type. All statistical analyses were performed using standard software packages (SPSS 21; IBM, Armonk, New York). A P value of less than .05 was considered statistically significant. The institutional review board at NYU Langone Medical Center did not require submission of this study for approval.
Results
The survey was completed by 52 people (5% response rate). The majority of respondents was younger than 40 years (58%), female (52%), and worked at institutions in the United States (79%) with 750 or fewer beds (52%). The institutions represented were 67% academic, 21% community, 8% private, and 4% government, and 85% had a dedicated neurosciences ICU. Additional data on the respondents' roles and fields are shown in Figure 1 .
Routine use of EVDs was reported by every respondent except 1. The manner in which the remaining 51 respondents' institutions addressed VRI prevention is shown in Table 1 . Antibiotic-impregnated catheter (AIC) and conventional catheter (CC) use were reported with similar frequency (53% vs 47%), but no respondents reported routine use of silver-impregnated catheters (SICs). Although most respondents (69%) reported routine use of antibiotics at the time of EVD placement, administration of PPSA varied, with nearly half of the respondents indicating PPSAs were not used with EVDs at their institution. Nearly all (80%) respondents reported CSF collection only on an as-needed basis. Only 2 The majority of respondents were either neutral or disagreed with the need for PPSA with all catheter types (CC: 75%, AIC: 85%, and SIC: 87%), as shown in Figure 2 . The intraclass correlation coefficient was 0.843, indicating that respondents generally felt similarly about the need for PPSA regardless of the catheter type. Although there was no significant relationship between respondent role and belief that PPSA was indicated for any catheter type (P ¼ .16 for CC, P ¼ .06 for AIC, and P ¼ .41 for SIC), the 6 pharmacist respondents universally disagreed or disagreed strongly with the need for PPSA with AIC. There was no significant relationship between age and belief that PPSA was indicated for any catheter type (P ¼ .93 for CC, P ¼ .19 for AIC, and P ¼ .99 for SIC).
Discussion

Catheter Selection
Use of CC and AIC was evenly divided among our respondents. A prospective randomized controlled trial (RCT) at 6 centers showed that bacterial growth from CSF cultures was 7 times less frequent in patients with AIC in comparison to those with standard catheters. 8 Wang et al performed a systematic review and meta-analysis on the efficacy of AIC and looked at 4 RCTs and 4 nonrandomized prospective trials and found a significant reduction in CSF infections with the use of AIC. 9 Another meta-analysis of 4 randomized and 10 observational studies noted a risk reduction of 62% (P < .00001) in patients with AIC in comparison to CC. 25 A review of the literature from 1966 to 2011 revealed 11 in vivo and 4 in vitro studies and concluded that AICs decrease the incidence of CSF pathogen growth but noted that the relationship between the presence of positive bacterial cultures and the development of clinical ventriculitis is unclear. 5 A cost analysis of 6 studies in the literature (2 RCTs and 4 prospective cohort trials) demonstrated that in comparison to CC, AIC may be associated with 2.7 fewer deaths, 82 fewer hospital days due to infection, and a savings of US$264 069 per 100 patients. 26 Although none of the survey respondents reported the use of SIC, Silver Impregnated Line Versus EVD Randomized Trial, a double-blind prospective RCT showed that in comparison to CC, SICs were associated with a lower risk of infection (P ¼ .04). 6 A pooled analysis of 1 RCT and 1 nonrandomized prospective study also showed reduction in rate of infections with SIC, but this result was not significant (P ¼ .18). 9 A systematic review and meta-analysis looked at 36 studies (16 796 procedures) and concluded that both AIC and SIC were associated with reduction in CSF infections in comparison to CC. Two studies (an RCT and a prospective cohort study) compared SIC and AIC and found no difference in rate of infection in either study or in the pooled analysis. Non-CC use was associated with increased methicillin-resistant Staphylococcus aureus, nonstaphylococcal, and gram-negative bacterial infections, 11 but a separate meta-analysis showed similar rates of resistant infections in patients with CC and AIC. Notably, the use of PPSA was inconsistent among studies reviewed. 9 Despite these data, nearly half of our respondents reported routine use of CC. Given the multitude of studies that demonstrated decreased morbidity, mortality, and rate of VRI with AIC, 9, 25, 26 we believe these catheters should be favored over CC. Further research is warranted to determine whether AICs are superior to SIC.
Maintenance Antibiotics
In 1999, a survey of 36 university neurosurgical programs revealed that 72% of institutions queried started PPSA in patients with EVDs. 14 Results from single-center studies showed mixed results, though, with some demonstrating a significant decrease in risk of infections with PPSA 15, 16 and some showing no significant difference in rate of VRI with or without PPSA. 12, 13, 20, 27 A systematic review of 3 RCTs and 7 observational studies showed a protective effect of PPSA but noted that there was no sufficient data to compare the benefits of PPSA with those of AIC or to definitively determine whether both therapies should be used in conjunction. 7 In a prospective performance analysis, Murphy et al looked at 410 patients with AIC on PPSA and compared them to 135 patients with AIC and no systemic antibiotics, and they found no statistically significant difference in rates of VRI between the 2 groups. 3 In a prospective RCT, Wong et al compared the use of PPSA with CC to the use of AIC without PPSA and found no significant difference in rate of CSF infection, ICU length of stay, or functional outcome. 10 Discontinuation of PPSA resulted in a significant reduction in rates of nosocomial infections. 3, 27 Additionally, PPSAs have been associated with the growth of resistant or opportunistic pathogens. 12, 16, 21 Cessation of PPSA use was estimated to lead to US$80 000 of annual savings in direct drug costs at 1 institution 12 and US$162 516 of annual savings in both drug costs and costs of treatment for nosocomial infections at another. 3 Although the data suggest that discontinuation of PPSA prevents complications and decreases cost of hospitalization without incurring increased risk of infection, 3, 10, 12, 13, 20, 27 55% of the respondents indicated their institutions still use PPSA. Notably, despite the fact that this issue remains controversial, the trend seems to be toward less frequent use of PPSA as compared to the 72% of respondents who reported the use of PPSA in the study of Prabhu et al in 1999. 14 
Respondents
generally felt similarly about the need for PPSA regardless of the catheter type, but we found that pharmacists had the highest predilection for discontinuing PPSA in the setting of AIC. This indicates that pharmacists are up-to-date on this topic and demonstrate their potential to educate other health professionals on relevant data to influence practice. 28 
Cerebrospinal Fluid Sampling
Frequency of CSF sampling varied among respondents, but 80% indicated it was only performed on an as-needed basis and 20% reported it was performed either daily or routinely. Although Arabi et al demonstrated that the frequency of CSF sampling had no effect on rate of VRI, 17 other studies have noted reduction in the rate of VRI with lower sample frequency. 18, 19 Frequent CSF sampling may increase the likelihood of introduction of bacteria into the sterile system. 18 Furthermore, because CSF can be expected to be abnormal in patients with underlying diseases that require ventricular drainage, the value of routine CSF analysis for prediction of VRI is limited. Schade et al found that CSF glucose, protein, and leukocyte count were comparable in patients with infection and those without infection and noted that no CSF parameter had both sensitivity and specificity greater than 60% for the diagnosis of VRI. 29 
Venue for EVD Placement
Catheter placement outside the operating suite was shown to have a trend toward increased rate of VRI (P ¼ .06) in a singlecenter prospective study. 17 In a prospective multicenter Italian study, Citerio et al found a statistically significant (odds ratio: 4.01, P ¼ .05) difference in the rate of VRI based on venue of EVD placement. 30 However, Lozier et al noted in a review that in 5 studies on the relationship between venue of EVD placement and risk of VRI, there was no significant difference in infection rate regardless of whether the drain was placed in the ICU, operating room, or emergency department. 21 With a strict infection prevention protocol, Murphy et al reported a very low incidence (0.92%) of VRI, despite the fact that catheters were predominantly placed in the ICU. 3 The majority of survey respondents (73%) noted that EVDs were routinely placed outside the operating room at their institutions. This allows for the rapid ability to monitor intracranial pressure and treat hydrocephalus. 31 Risk of VRI can be minimized under these circumstances via a multidisciplinary effort to create and adhere to a meticulous standardized protocol for EVD insertion, maintenance, and management. [32] [33] [34] [35] 
Prophylactic EVD Exchange
In 1984, Mayhall et al found a significantly higher risk of infection in patients who had EVDs present for greater than 5 days (P ¼ .017) and concluded that if monitoring is required for more than 5 days, the catheter should be removed and reinserted at a different site. 22 Holloway et al subsequently conducted a retrospective analysis at Medical College of Virginia and found that prophylactic exchange at 5 days did not reduce the rate of infection in comparison to exchange after 5 days. 23 A review of the literature showed that of 17 studies evaluating the effect of duration of catheterization on risk for VRI, 10 reported longer duration was associated with increased risk of infection and 7 reported no association between duration of catheterization and risk of infection. Although the effect of EVD duration on risk of infection varied, the effect of prophylactic catheter exchange on the development of subsequent infections was unknown, 21 so Wong et al conducted a prospective RCT involving planned catheter exchange after 5 days. The RCT showed a higher rate of VRI in patients with planned exchanges (7.8%) in comparison to those whose catheters were left in place as long as clinically indicated (3.8%), but this difference was not significant (P ¼ .5). 36 In line with these findings, 96% of respondents to our survey noted that EVDs were not routinely exchanged at their institutions.
Other Methods to Prevent VRI
It is important to note that in addition to the aforementioned aspects of care that can impact rates of VRI, variation in other practices including aseptic technique, hair removal, skin preparation, and dressings also affect the frequency of VRI. It is ideal to have a standardized institutional protocol for EVD insertion, maintenance, and management. It is also necessary to ensure that EVDs are monitored to ensure compliance with the protocol and that education about VRI prevention occurs regularly. 37 
Limitations
There are inherent limitations to the results of practice surveys, and our results represent current practice but not necessarily best practice or even desired practice. We only asked respondents their opinions on PPSA usage, but it is feasible that a respondent disagreed with institutional practice (for example, a respondent who wanted to use AIC but did not have them available at their institution). This desire would not have been captured by our survey questions.
Our cohort includes only a small sample of the membership of the Neurocritical Care Society, but we feel that the variety of responses we received effectively demonstrates that there is a diverse range of VRI prevention strategies. Although the group was very heterogeneous and only 49% of respondents were physicians (and of the physicians, only a few were neurosurgeons), we believe that as members of the Neurocritical Care Society, all respondents were in positions that would allow them to be well versed in their institutional EVDrelated policies and practices. The survey was voluntary, so we believe that respondents would only complete it if they were familiar with EVD management at their institutions, but this could introduce a voluntary response bias to our findings. Because every survey question was mandatory and we did not include an ''I don't know'' option for any questions, if a respondent did not know the answer to a question, they may have chosen to arbitrarily select a response, resulting in a response bias. This could compromise the quality, credibility, and actuality of our findings. The majority of the respondents worked at academic institutions in the United States, which may limit generalizability.
We did not collect data on respondents' institutions, so there was no mechanism to control for multiple responses from a single institution, which could introduce sample bias. In addition, we did not ask respondents whether their institutions had local protocols on EVD management and if they were personally involved in directing these protocols.
Conclusion
Practice patterns demonstrate that institutions use varying strategies to prevent VRIs. We found that there was the greatest disparity in catheter selection and use of PPSA. Venue of EVD placement and frequency of CSF collection provoked less varied responses. Routine catheter exchange was nearly universally not performed at respondents' institutions. Optimizing care for these patients through creation of practice standards is essential to decrease the risk of complications.
Appendix A
Infection Prevention in Neurocritical Care
The following is a brief survey about infection prophylaxis practices in neurocritical care patients. All responses are anonymous. The goal of this survey is to identify trends in practice for infection prevention in neurocritical care. The results of the survey will be used to produce a manuscript for presentation/publication. The survey should take less than 10 minutes to complete.
What country do you practice in?
- Are intravenous antibiotics routinely given at the time of external ventricular drain placement at your institution?
Yes No
Are intravenous antibiotics routinely used as prophylaxis throughout the time that the external ventricular drain is in place?
How often do you send cerebrospinal fluid samples from external ventricular drains?
Daily Routinely (but less frequently than daily) As needed if there is concern for ventriculitis Are external ventricular drain catheters routinely exchanged at your institution for the goal of trying to decrease risk of infection?
In which of the following scenarios, are prophylactic intravenous MAINTENANCE antibiotics routinely administered after device placement at your drain institution? (Check all that are applicable) 
